Meet-and-Greet Cleerly Leadership
On Sunday, November 12, meet with Cleerly founder and CEO, James K. Min, MD, and the Cleerly leadership team to ask questions and discuss.
Heart-healthy snacks will be provided at Booth 1738!
2:00 — 3:00 PM
James K. Min, MD
Founder and CEO, Cleerly
Udo Hoffmann, MD
Chief Scientific Officer, Cleerly
James Earls, MD
Chief Medical Officer, Cleerly
Jim Hartman
Chief Revenue Officer, Cleerly
Patents
Cleerly continues to revolutionize heart attack and cardiovascular disease prevention and treatment everyday by inventing world-class technology. Cleerly invests significant time and resources in research and development towards this goal. To protect Cleerly’s research and development efforts, Cleerly has vigorously developed a robust intellectual property portfolio – all part of a strategy for protecting the innovations that make Cleerly an industry leader in cardiovascular disease prevention and treatment.
Cleerly’s products and services may be covered by or for use under one or more of U.S. Patent Nos. 10,813,612, 11,094,060, 11,094,061, 11,113,811, 11,120,549, 11,120,550, 11,132,796, 11,210,786, 11,232,564, 11,238,587, 11,244,451, 11,276,170, 11,288,799, 11,302,001, 11,302,002, 11,308,617, 11,315,247, 11,317,883, 11,321,840, 11,341,644, 11,350,899, and 11,367,190, as well as other patents that are pending.
For additional information, please contact legal@cleerlyhealth.com.
Solutions
About
© 2024 Cleerly, Inc.